The useful question is what changes for users, developers or buyers, and whether the announcement stays industry context or becomes something people can actually use.

People with lower-limb injuries often rely on intensive, hands-on physiotherapy to relearn walking, a process that is physically demanding for both patients and therapists. Traditional methods require prolonged sessions with continuous expert supervision, limiting scalability and precision. Onyx Healthcare, a Taiwan-based medical device manufacturer, partnered with Intel and FREE Bionics to develop FREE Walk, an AI-driven exoskeleton designed to address these challenges by providing consistent, repetitive movement guidance during rehabilitation.

The FREE Walk exoskeleton integrates Intel’s Core Ultra series CPUs and OpenVINO software stack to process real-time sensor data from pressure, electromyography (EMG), and inertial sensors. These components translate bio-electric muscle signals into predictive movement adjustments, enhancing gait stability. The system operates locally at the edge, enabling low-latency AI inference while leveraging OpenVINO to optimize AI model deployment across CPU, NPU, and GPU resources for improved performance and scalability.

According to John Chuang, president of Onyx Healthcare, the Intel-based platform has transformed smart rehabilitation from a theoretical concept into a practical medical solution. The technology supports local edge AI processing during training, with accumulated data later reviewed in the cloud for continuous product improvement. This approach balances real-time responsiveness with long-term learning, ensuring both immediate patient needs and future advancements are addressed.

Today, FREE Walk exoskeletons are used in approximately one-third of medical-center-level hospitals in Taiwan, reducing therapist staffing requirements by at least two professionals per session—improving efficiency by roughly 50%. The system has logged over 40,000 patient training records across 22 countries. Onyx Healthcare and Intel plan to expand their collaboration to further integrate advanced AI technologies into safe, reliable medical-grade solutions for clinical environments.